Federal - HR 712

VA Medicinal Cannabis Research Act of 2019

Introduced

January 23, 2019

Description

A bill to direct the Secretary of Veterans Affairs to carry out a clinical trial of the effects of cannabis on certain health outcomes of adults with chronic pain and post-traumatic stress disorder, and for other purposes.

Our Position

Support

Original Sponsor 1

Co-Sponsors 104

Latest Actions See More/Less

  • March 12, 2020 — Full committee consideration and markup held by the House Veterans' Affairs Committee.

    March 12, 2020 — Committee Vote: VA Medical Marijuana Research — Benefit Guarantee
      Steube, R-Fla. —

    Amendment to the Roe, R-Tenn., substitute amendment that would add language to guarantee that veterans who participate in state-approved medical marijuana programs cannot be denied benefits from the Department of Veterans Affairs.

    The amendment also would require the secretary of Veterans Affairs to ensure that Veterans Health Administration physicians and other health providers discuss cannabis use with veterans enrolled in the annual patient enrollment system and who participate in state-approved medical marijuana programs and adjust their medical treatment plans accordingly. It also would require the secretary to record such use in the veteran's medical records.

    Amendment to the Roe, R-Tenn., substitute amendment that would add language to guarantee that veterans who participate in state-approved medical marijuana programs cannot be denied benefits from the Department of Veterans Affairs.

    The amendment also would require the secretary of Veterans Affairs to ensure that Veterans Health Administration physicians and other health providers discuss cannabis use with veterans enrolled in the annual patient enrollment system and who participate in state-approved medical marijuana programs and adjust their medical treatment plans accordingly. It also would require the secretary to record such use in the veteran's medical records.

    Adopted by voice vote.

    March 12, 2020 — Committee Vote: VA Medical Marijuana Research — Substitute Amendment
      Roe, R-Tenn. —

    Substitute amendment that would strike language to require the secretary of Veterans Affairs to carry out a double-blind randomized clinical trial on the effects of medical-grade cannabis on the health outcomes of veterans diagnosed with chronic pain and post-traumatic stress disorder.

    Instead of the clinical trial, the amendment would require the secretary to conduct and support research on the effects of medical-grade cannabis on the health outcomes of veterans diagnosed with chronic pain and post-traumatic stress disorder.

    As amended, it would guarantee that veterans who participate in a clinical trial or study conducted related to such research or participate in state-approved medical marijuana programs cannot be denied benefits from the Department of Veterans Affairs.

    As amended, it also would require the secretary to ensure that Veterans Health Administration physicians and other health providers discuss cannabis use with veterans enrolled in the annual patient enrollment system, and who participate in state-approved medical marijuana programs, and adjust their medical treatment plans accordingly. It also would require the secretary to record such use in the veteran's medical records.

    Substitute amendment that would strike language to require the secretary of Veterans Affairs to carry out a double-blind randomized clinical trial on the effects of medical-grade cannabis on the health outcomes of veterans diagnosed with chronic pain and post-traumatic stress disorder.

    Instead of the clinical trial, the amendment would require the secretary to conduct and support research on the effects of medical-grade cannabis on the health outcomes of veterans diagnosed with chronic pain and post-traumatic stress disorder.

    As amended, it would guarantee that veterans who participate in a clinical trial or study conducted related to such research or participate in state-approved medical marijuana programs cannot be denied benefits from the Department of Veterans Affairs.

    As amended, it also would require the secretary to ensure that Veterans Health Administration physicians and other health providers discuss cannabis use with veterans enrolled in the annual patient enrollment system, and who participate in state-approved medical marijuana programs, and adjust their medical treatment plans accordingly. It also would require the secretary to record such use in the veteran's medical records.

    Adopted (as amended) by voice vote.

    March 12, 2020 — Committee Vote: VA Medical Marijuana Research — Vote to Report

    Require the secretary of Veterans Affairs to conduct and support research on the effects of medical-grade cannabis on the health outcomes of veterans diagnosed with chronic pain and post-traumatic stress disorder.

    The bill would ensure that such research is done in accordance with applicable regulations concerning oversight of research.

    The bill would specify that such research must include a mechanism to ensure the preservation of all data collected or used on the effects of cannabis on health outcomes is done in a way that allows for further research.

    The bill would specify the forms of cannabis to be researched including full plants and extracts, and at least three different strains of cannabis.

    The bill also would specify that a veteran who participates in a clinical trial or study conducted related to such research would still be eligible for benefits from the Department of Veterans Affairs.

    As amended, the bill would guarantee that veterans who participate in a clinical trial or study conducted related to such research or participate in state-approved medical marijuana programs cannot be denied benefits from the Department of Veterans Affairs.

    As amended, the bill also would require the secretary to ensure that Veterans Health Administration physicians and other health providers discuss cannabis use with veterans enrolled in the annual patient enrollment system, and who participate in state-approved medical marijuana programs, and adjust their medical treatment plans accordingly. It also would require the secretary to record such use in the veteran's medical records.

    The bill would require the secretary, during a five-year period beginning on the enactment date, to periodically, but at least annually, submit reports to Congress on such research.

    Require the secretary of Veterans Affairs to conduct and support research on the effects of medical-grade cannabis on the health outcomes of veterans diagnosed with chronic pain and post-traumatic stress disorder.

    The bill would ensure that such research is done in accordance with applicable regulations concerning oversight of research.

    The bill would specify that such research must include a mechanism to ensure the preservation of all data collected or used on the effects of cannabis on health outcomes is done in a way that allows for further research.

    The bill would specify the forms of cannabis to be researched including full plants and extracts, and at least three different strains of cannabis.

    The bill also would specify that a veteran who participates in a clinical trial or study conducted related to such research would still be eligible for benefits from the Department of Veterans Affairs.

    As amended, the bill would guarantee that veterans who participate in a clinical trial or study conducted related to such research or participate in state-approved medical marijuana programs cannot be denied benefits from the Department of Veterans Affairs.

    As amended, the bill also would require the secretary to ensure that Veterans Health Administration physicians and other health providers discuss cannabis use with veterans enrolled in the annual patient enrollment system, and who participate in state-approved medical marijuana programs, and adjust their medical treatment plans accordingly. It also would require the secretary to record such use in the veteran's medical records.

    The bill would require the secretary, during a five-year period beginning on the enactment date, to periodically, but at least annually, submit reports to Congress on such research.

    Ordered reported favorably to the full House (as amended) by voice vote.
  • March 11, 2020 — Additional cosponsor(s): 1

    Steube, (R-Fla.)
  • Feb. 14, 2020 — Additional cosponsor(s): 2

    Levin, (D-Calif.)Peterson, (D-Minn.)
  • Jan. 15, 2020 — Additional cosponsor(s): 1

    Morelle, (D-N.Y.)
  • Jan. 13, 2020 — Additional cosponsor(s): 4

    Kelly, R. (D-Ill.)Sires, (D-N.J.)
    Kilmer, (D-Wash.)Trahan, (D-Mass.)
  • Jan. 9, 2020 — Additional cosponsor(s): 3

    Davis, D. (D-Ill.)Foster, (D-Ill.)Payne (D-N.J.)
  • Dec. 17, 2019 — Additional cosponsor(s): 1

    Napolitano, (D-Calif.)
  • Dec. 3, 2019 — Additional cosponsor(s): 1

    Thompson, B. (D-Miss.)
  • Nov. 15, 2019 — Additional cosponsor(s): 3

    Horn, (D-Okla.)Joyce, (R-Ohio)Tlaib, (D-Mich.)
  • Nov. 14, 2019 — Additional cosponsor(s): 1

    Sherman, (D-Calif.)
  • Oct. 23, 2019 — Additional cosponsor(s): 1

    Wild, (D-Pa.)
  • Oct. 22, 2019 — Additional cosponsor(s): 3

    Delgado, (D-N.Y.)Lowenthal, (D-Calif.)Neguse, (D-Colo.)
  • Sept. 19, 2019 — Additional cosponsor(s): 1

    Evans, (D-Pa.)
  • Sept. 18, 2019 — Additional cosponsor(s): 2

    Collins, C. (R-N.Y.)Pressley, (D-Mass.)
  • Sept. 16, 2019 — Additional cosponsor(s): 2

    Nadler, (D-N.Y.)Serrano, (D-N.Y.)
  • Sept. 6, 2019 — Additional cosponsor(s): 3

    Jayapal, (D-Wash.)McGovern, (D-Mass.)Velazquez, (D-N.Y.)
  • Aug. 6, 2019 — Additional cosponsor(s): 1

    Escobar, (D-Texas)
  • July 30, 2019 — Additional cosponsor(s): 3

    Aguilar, (D-Calif.)McCollum, (D-Minn.)Roybal-Allard, (D-Calif.)
  • July 17, 2019 — Additional cosponsor(s): 1

    Porter, (D-Calif.)
  • July 15, 2019 — Additional cosponsor(s): 1

    Huffman, (D-Calif.)
  • July 10, 2019 — Additional cosponsor(s): 1

    Eshoo, (D-Calif.)
  • July 9, 2019 — Additional cosponsor(s): 1

    Meng, (D-N.Y.)
  • June 27, 2019 — Additional cosponsor(s): 2

    DelBene, (D-Wash.)King, P. (R-N.Y.)
  • June 20, 2019 — Full committee hearing held by the House Veterans' Affairs Committee.

  • June 11, 2019 — Additional cosponsor(s): 1

    Meeks, (D-N.Y.)
  • June 5, 2019 — Additional cosponsor(s): 1

    Raskin, (D-Md.)
  • May 28, 2019 — Additional cosponsor(s): 2

    Garcia, (D-Ill.)Omar, (D-Minn.)
  • May 8, 2019Consideration and markup deferred by the House Veterans' Affairs Committee.

  • May 7, 2019 — Additional cosponsor(s): 2

    Cardenas, (D-Calif.)Ruiz, (D-Calif.)
  • April 18, 2019 — Additional cosponsor(s): 1

    Hayes, (D-Conn.)
  • April 12, 2019 — Additional cosponsor(s): 2

    Kennedy, Joseph P. (D-Mass.)Lujan, B.R. (D-N.M.)
  • April 8, 2019 — Additional cosponsor(s): 2

    Crow, (D-Colo.)Rouda, (D-Calif.)
  • April 3, 2019 — Additional cosponsor(s): 3

    Heck, (D-Wash.)Moulton, (D-Mass.)Rice, K. (D-N.Y.)
  • April 1, 2019 — Additional cosponsor(s): 1

    Kim, (D-N.J.)
  • March 25, 2019 — Additional cosponsor(s): 2

    Haaland, (D-N.M.)Maloney, S.P. (D-N.Y.)
  • March 14, 2019 — Additional cosponsor(s): 2

    Hill, (D-Calif.)Lamb, (D-Pa.)
  • March 7, 2019 — Additional cosponsor(s): 5

    Hastings, (D-Fla.)Kuster, (D-N.H.)Smith, Adam (D-Wash.)
    Horsford, (D-Nev.)Rush, (D-Ill.)
  • Feb. 28, 2019 — Additional cosponsor(s): 4

    Cisneros, (D-Calif.)Rose, (D-N.Y.)
    Gabbard, (D-Hawaii)Yarmuth, (D-Ky.)
  • Feb. 15, 2019 — Additional cosponsor(s): 4

    Crist, (D-Fla.)Panetta, (D-Calif.)
    Dean, (D-Pa.)Perlmutter, (D-Colo.)
  • Feb. 13, 2019 — Additional cosponsor(s): 3

    Brindisi, (D-N.Y.)Waltz, (R-Fla.)Welch, (D-Vt.)
  • Feb. 6, 2019 — Additional cosponsor(s): 5

    Espaillat, (D-N.Y.)Quigley, (D-Ill.)Watson Coleman, (D-N.J.)
    Luria, (D-Va.)Soto, (D-Fla.)
  • Jan. 29, 2019 — Additional cosponsor(s): 8

    DeGette, (D-Colo.)Johnson, H. (D-Ga.)Pingree, (D-Maine)
    Gallego, (D-Ariz.)Lofgren, (D-Calif.)Swalwell, (D-Calif.)
    Himes, (D-Conn.)Peters, S. (D-Calif.)
  • Jan. 25, 2019 — Additional cosponsor(s): 16

    Blumenauer, (D-Ore.)Grijalva, (D-Ariz.)Schakowsky, (D-Ill.)
    Brownley, (D-Calif.)Jones, (R-N.C.)Takano, (D-Calif.)
    Carbajal, (D-Calif.)Khanna, (D-Calif.)Titus, (D-Nev.)
    Cohen, (D-Tenn.)Lee, B. (D-Calif.)Young, Don (R-Alaska)
    DeFazio, (D-Ore.)Norton, (D-D.C.)
    Gaetz, (R-Fla.)Pocan, (D-Wis.)
  • Jan. 23, 2019 — Original cosponsor(s): 1

    Higgins, C. (R-La.)
  • Jan. 23, 2019 — Read twice and referred to: House Veterans' Affairs.Congressional Record p. H1170